CRP and head and neck carcinoma: Studies have shown the correlation of survival outcome in patients with head and neck carcinoma with several different inflammation-associated markers such as the neutrophil-to-lymphocyte ratio (NLR) [8,9], platelet-to-lymphocyte ratio (PLR) [10], and C-reactive protein (CRP) [11].